Label-Free, LC-MS-Based Assays to Quantitate Small-Molecule Antagonist Binding to the Mammalian BLT1 Receptor

The TZD insulin sensitizer clue provides a new route into diabetes drug discovery

(2015) Jerry R. Colca   Expert Opinion on Drug Discovery

LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes

(2015) Pingping Li et al.   NATURE MEDICINE

Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor  

(2013) K. Wejksza et al.   JOURNAL OF IMMUNOLOGY

Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-Induced Obesity

(2011) M. Spite et al.   JOURNAL OF IMMUNOLOGY

MS Binding Assays-with MALDI toward High Throughput

(2009) Georg Höfner et al.   ChemMedChem

Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1

(2008) Christine Zepperitz et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Affinity Selection-Mass Spectrometry and its Emerging Application to the High Throughput Screening of G Protein-Coupled Receptors

(2008) Charles Whitehurst et al.   COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING